In silico exploration for identifying structure-activity relationship of MEK inhibition and oral bioavailability for isothiazole derivatives
Date
2010Author
Melagraki, G.![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
Sarimveis, H.
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
![ORCID logo](https://orcid.org/sites/default/files/images/orcid_16x16.png)
Kollias, G.
ISSN
1747-0277Source
Chemical Biology and Drug DesignVolume
76Issue
5Pages
397-406Google Scholar check
Keyword(s):
Metadata
Show full item recordAbstract
In this study, quantitative structure-activity/property models are developed for modeling and predicting both MEK inhibitory activity and oral bioavailability of novel isothiazole-4-carboxamidines. The models developed are thoroughly discussed to identify the key components that influence the inhibitory activity and oral bioavailability of the selected compounds. These selected descriptors serve as a first guideline for the design of novel and potent MEK inhibitors with desired ADME properties. © 2010 John Wiley & Sons A/S.